CVMW2022 心血管代謝週間 第6回日本循環器学会 基礎研究フォーラム（BCVR）【採択演題一覧:登録ID順】
会場:ステーションコンファレンス東京
全て「口演発表」となります。なお、Web上でのご登壇も可能でございます。
登録ID

セッション名id001

Abstract Session
Short presentation1

演題番号O1-BC-8

id002

Abstract Session
Short presentation2

O2-BC-2Overexpression of vascular G protein-coupled receptor kinase 2 (GRK2) leads touncontrolled hypertension and acute heart failure as in Clinical Scenario 1

id003

Abstract Session
Short presentation1

O1-BC-4

Reduced Proteolytic Cleavage of von Willebrand Factor Leads to Endothelial Thrombo-Inflammatory Activation andPlaque Progression after Myocardial Infarction

id004

Abstract Session
Short presentation4

O4-BC-5

id005

Abstract Session
Short presentation4

O4-BC-10

id006

Abstract Session
Short presentation3

id007

Abstract Session
Short presentation3

O3-BC-1

id009

Abstract Session
Short presentation2

O2-BC-9

id010

Abstract Session
Short presentation2

id012

Abstract Session
Short presentation3

O3-BC-7

id013

Award Session

AS-BC-4

id014

Abstract Session
Short presentation4

id015

Abstract Session
Short presentation2

O2-BC-1

id018

Abstract Session
Short presentation4

O4-BC-1

id019

Abstract Session
Short presentation2

id020

Abstract Session
Short presentation2

O2-BC-8

id021

Abstract Session
Short presentation3

O3-BC-2

id022

Abstract Session
Short presentation1

O1-BC-6

id023

Abstract Session
Short presentation4

O4-BC-7

id024

Abstract Session
Short presentation4

id025

Abstract Session
Short presentation3

O3-BC-6

id026

Abstract Session
Short presentation4

O4-BC-2

id027

Abstract Session
Short presentation2

O2-BC-4

id028

Abstract Session
Short presentation1

O1-BC-3

id029

Abstract Session
Short presentation3

O3-BC-8

id030

Abstract Session
Short presentation3

id032

Abstract Session
Short presentation4

O4-BC-9

id034

Award Session

AS-BC-1

id036

Abstract Session
Short presentation3

id037

Abstract Session
Short presentation4

O4-BC-6

id038

Abstract Session
Short presentation4

O4-BC-4

id039

Abstract Session
Short presentation3

id040

Abstract Session
Short presentation2

O2-BC-6

id041

Abstract Session
Short presentation1

O1-BC-1

id042

Award Session

AS-BC-5

id045

Abstract Session
Short presentation1

O1-BC-5

id047

Award Session

AS-BC-2

id049

Abstract Session
Short presentation1

id050

Abstract Session
Short presentation2

O2-BC-5

id052

Award Session

AS-BC-3

id053

Abstract Session
Short presentation1

id055

Abstract Session
Short presentation1

O3-BC-3

O2-BC-7

O4-BC-8

O2-BC-3

O4-BC-3

O3-BC-9

O3-BC-4

O3-BC-5

O1-BC-9

O1-BC-2
O1-BC-7

演題名
Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells

The Curcumin Analogue GO-Y022 Improves Pressure Overload-induced Systolic Dysfunction
Cardioprotective peptide GJA1-20k activates mitochondria to protect against ischemia-reperfusion injury
A Kinome-wide CRISPR Screening identifies TAOK1 as a Potential Therapeutic Target for Doxorubicin-induced Cardiotoxicity
Treatment with atrial natriuretic peptide ameliorates myocardial insulin resistance andprotects against ischemia-reperfusion injury in diet-induced obesity
DNA damage predicts therapeutic prognosis in heart failure with reduced ejection fraction of various underlying diseases
Mechanistic insight of SGLT2 inhibitors on epicardial adipose tissue
Myonectin protects against age-related muscle atrophy by modulating mitochondrial function
Proximal Renal Tubule derived Semaphorin 3C Regulates Pathological Cardiac Hypertrophy in Cardio-Renal Syndrome
Lipin1 prevents ischemic heart disease by regulating lipid homeostasis
A Pacing-Controlled Protocol for Frequency-Diastolic Relations Distinguishes Diastolic Dysfunction Specific to A Mouse HFpEF Model
Myofilament protein post-translational modifications may underlie right ventricular dysfunction in pulmonary hypertension
Dantrolene improves diastolic property of left ventricle in mineralcorticoid-induced hypertensive rats
SGLT2 inhibitor Empagliflozin protects against heart failure through inhibition ofinflammatory responses mediated by bone marrow-derived immune cells in micecFOS/cJUN mediated signaling in brown adipose tissue promotes pathologies in HFpEF and NASH
Gut Microbiota Influence the Development of Abdominal Aortic Aneurysm by Suppressing Macrophage Accumulation
Soy protein β-conglycinin Attenuates Cardiac Hypertrophy and Heart Failure by Regulation of Gut Microbiota
Multimerization of GATA4 is required for hypertrophic responses in cultured cardiomyocytes
Depressive stress induces heart failure through hematoimmune system
Higher-order structure of genome plays an important role in maintaining nuclear homeostasis of cardiomyocytes
RyR2-targeting therapy prevents ventricular tachycardia and left ventricular remodeling after myocardial infarction
Endothelial-specific inactivation of non-nuclear estrogen receptor-α signaling impairs estrogen protection against vascular injury
Inhibition of N-terminal acetyltransferase C prevents muscle atrophy in cancer cachexia
Nerve Growth Factor/Tropomyosin Receptor Kinase A signaling pathway plays a vital role inbreast cancer progression after myocardial infarction
Progranulin deficiency promotes adverse cardiac remodeling after myocardial infarction
CD163+ Macrophages Restrain Vascular Calcification, Promoting the Development of High-Risk PlaqueNobiletin, a polymethoxy flavonoid, inhibits doxorubicin-induced myocardial damage
Cardiomyocyte hypertrophy is regulated by p300 binding protein 1, a novel binding protein
The p300 Histone Acetyltransferase Inhibitor A485 Prevents Pressure Overload-induced Cardiac Dysfunction
Aging is associated with decreased chemokine expression in cardiac tissue macrophages
Expression of Angiopoietin-like 4 (ANGPTL4) in Epicardial Adipose Tissue Is Increased in Patients with Coronary Artery Disease
Physiological importance of ALK1 signaling for vascular formation in various organs of zebrafish embryos
Modeling SARS-CoV-2 spike receptor-binding domain-mediated inflammatory responseusing human induced pluripotent stem cell-derived cardiomyocytes
Inhibition of MicroRNA-33b Specifically Ameliorates Abdominal Aortic Aneurysm Formation via Suppression of Inflammatory Pathways
Development of new agent for pulmonary vascular disease~ A strategy targeting pathological high shear stress exerted on the pulmonary arteries ~Production of Mature Engineered Heart Tissues with Heart-derived Collagen
Systemic administration of Empagliflozin Decreases Myocardial Interstitial Myoglobin Levels in Ischemia/Reperfusion RatsA Novel mouse model of aortic dissection caused by a point mutation in the hybrid domain of the fibrillin-1 gene
Relationship between miR206 secreted from growing skeletal muscle and angiogenic response in endothelial cells
Single cell analysis on the transitional state from Mesp1 -expressing cardiac mesoderm cells to
cardiac progenitor cells during heart development

発表日

セッション時間

12月16日（金）17:10～18:00

12月17日（土）14:00～14:50

12月16日（金）17:10～18:00

12月17日（土）16:00～16:50

12月17日（土）16:00～16:50

12月17日（土）15:00～15:50

12月17日（土）15:00～15:5012月17日（土）14:00～14:50

12月17日（土）14:00～14:50

12月17日（土）15:00～15:50

12月17日（土）17:00～18:00

12月17日（土）16:00～16:50

12月17日（土）14:00～14:50

12月17日（土）16:00～16:50

12月17日（土）14:00～14:50

12月17日（土）14:00～14:50

12月17日（土）15:00～15:50

12月16日（金）17:10～18:00

12月17日（土）16:00～16:50

12月17日（土）16:00～16:50

12月17日（土）15:00～15:50

12月17日（土）16:00～16:50

12月17日（土）14:00～14:50

12月16日（金）17:10～18:00

12月17日（土）15:00～15:50

12月17日（土）15:00～15:50

12月17日（土）16:00～16:50

12月17日（土）17:00～18:00

12月17日（土）15:00～15:50

12月17日（土）16:00～16:50

12月17日（土）16:00～16:50

12月17日（土）15:00～15:50

会場名

第2会場

12月17日（土）14:00～14:50

12月16日（金）17:10～18:00

12月17日（土）17:00～18:00

12月16日（金）17:10～18:00

12月17日（土）17:00～18:00

12月16日（金）17:10～18:00

12月17日（土）14:00～14:50

12月17日（土）17:00～18:00

12月16日（金）17:10～18:00

12月16日（金）17:10～18:00